urmc.rochester.edu
Sep 17, 2026, 14:23
Neil Blumberg: ABO Nonidentical Transfusions and Mortality in Massive Transfusion
Neil Blumberg, Professor, Director of Transfusion Medicine/Blood Bank at University of Rochester Medical Center, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, published in Jama Surgery, adding:
“ABO mismatched transfusions likely harm patients experiencing severe hemorrhage undergoing massive transfusion protocol”
Title: ABO Nonidentical Transfusions and Mortality in Patients Undergoing Massive Transfusion Protocol
Authores: Neil Blumberg, Kelly Henrichs, Debra Masel, Michael Vella, Mark Gestring, Amanda Lippa, Phuong-Lan Nguyen, Akua Asante, Christine Cahill, Majed Refaai
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias
-
Sep 17, 2026, 14:51Konstantin Yenkoyan: Emicizumab and the Power of Translational Science